Loading...
OTCM
VYCO
Market cap2mUSD
Jul 08, Last price  
0.06USD
1D
0.00%
1Q
-20.69%
Jan 2017
-81.33%
IPO
217.25%
Name

Vycor Medical Inc

Chart & Performance

D1W1MN
OTCM:VYCO chart
P/E
P/S
1.14
EPS
Div Yield, %
Shrs. gr., 5y
5.04%
Rev. gr., 5y
10.29%
Revenues
2m
+17.24%
2,565129,947199,046316,450971,3671,205,2631,089,3741,250,2921,138,6341,452,7141,384,9711,509,3301,481,7511,142,0451,392,9871,222,9891,460,6041,589,3241,863,400
Net income
-72k
L-32.44%
-593,996-2,381,295-1,141,383-1,961,662-4,778,541-2,926,210-2,472,773-4,049,713-2,082,643-1,652,280-1,477,045-1,379,356-864,885-900,296-523,473-405,881-69,691-107,200-72,426
CFO
-13k
L
-429,633-1,171,622-543,786-1,450,270-3,195,334-1,370,930-730,143-2,700,769-1,167,500-496,918-527,438-260,3227,221-248,79121,369-217,01629,43060,110-13,471

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
IPO date
Mar 31, 2009
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT